Oncoustics Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 30

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 19

Oncoustics General Information

Description

Developer of advanced artificial intelligence (AI) technology designed for the treatment monitoring of diseases with high unmet clinical needs. The company applies AI to raw ultrasound signals to rapidly differentiate healthy versus diseased tissues that reveal novel acoustic biomarkers, enabling medical professionals to categorize tissue and serve as a virtual biopsy system.

Contact Information

Website
www.oncoustics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Primary Office
  • Nucleus at the MaRS Waterfront Waterfront Innovation Centre
  • Suite 200, Box 87 -155 Queens Quay E
  • Toronto, Ontario M5A 0W4
  • Canada
+1 (415) 000-0000

Oncoustics Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Oncoustics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Accelerator/Incubator 22-Jul-2023 00.000 Completed Generating Revenue
6. Later Stage VC 28-Feb-2023 00.000 Completed Generating Revenue
5. Seed Round 10-Jun-2022 00.00 00.000 Completed Generating Revenue
4. Accelerator/Incubator 01-Jan-2021 0000 00.000 Completed Startup
3. Seed Round 01-Jun-2018 00.000 00.000 Completed Startup
2. Accelerator/Incubator 01-Jun-2018 Completed Startup
1. Accelerator/Incubator 01-Nov-2012 Completed Stealth
To view Oncoustics’s complete valuation and funding history, request access »

Oncoustics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of advanced artificial intelligence (AI) technology designed for the treatment monitoring of diseases with hig
Diagnostic Equipment
Toronto, Canada
30 As of 2023
00.000
000000000000 00.000

00000

empor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis
0000000000 000000000
Ann Arbor, MI
00 As of 0000
000.00
00000000 000.00

00000

m ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex
0000000000 000000000
Vancouver, Canada
00 As of 0000
000.00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Oncoustics Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ENDRA Life Sciences Formerly VC-backed Ann Arbor, MI 00 000.00 00000000 000.00
00000 0000000 Venture Capital-Backed Vancouver, Canada 00 000.00 00000000000 000.00
00000000 Private Equity-Backed Paris, France 000 000.00 00000000000 000.00
You’re viewing 3 of 3 competitors. Get the full list »

Oncoustics Patents

  • 2

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 1

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Oncoustics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210077073-A1 Machine learning to extract quantitative biomarkers from rf spectrums Active 12-Dec-2017 000000000
US-11602330-B2 Machine learning to extract quantitative biomarkers from rf spectrums Active 12-Dec-2017 000000000 0

Oncoustics Executive Team (5)

Name Title Board Seat Contact Info
Beth Rogozinski Co-Founder, Chief Executive Officer & Board Member
Matt Hogan Chief Financial Officer
Sam Lee MD Chief Medical Advisor & Board Member
Ahmed El Kaffas Ph.D Co-Founder & Board Member
Annette Bianchi Advisor
To view Oncoustics’s complete executive team members history, request access »

Oncoustics Board Members (5)

Name Representing Role Since
Ahmed El Kaffas Ph.D Oncoustics Co-Founder & Board Member 000 0000
Beth Rogozinski Oncoustics Co-Founder, Chief Executive Officer & Board Member 000 0000
Chen Fong Saltagen Ventures Board Member 000 0000
James Wang Creative Ventures Board Member 000 0000
Sam Lee MD Oncoustics Chief Medical Advisor & Board Member 000 0000
To view Oncoustics’s complete board members history, request access »

Oncoustics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Oncoustics Investors (19)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Google for Startups Accelerator Accelerator/Incubator Minority 000 0000 000000 0
Cartography Capital Venture Capital Minority 000 0000 000000 0
Fraser Kearney Capital Corporation Minority 000 0000 000000 0
Plug and Play Tech Center Accelerator/Incubator Minority 000 0000 000000 0
Sony Innovation Fund Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 19 investors. Get the full list »

Ready to get started?

Request a free trial